All research
Semaglutide 2026-07-15 ClinicalTrials

Semaglutide Investigated for Modulating Brain Dopamine Responses to Food Cues in Obesity with Food Addiction

Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction Tendencies

Abstract

A clinical trial is assessing if semaglutide alters brain dopamine activity during food cue exposure and post-ingestion in adults with obesity and food addiction tendencies.


Source: clinicaltrials:NCT07732426 · Ingested 2026-08-04 · Digest: gemini-2.5-flash